dc.contributor.author | Ihira, Kei | |
dc.contributor.author | Dong, Peixin | |
dc.contributor.author | Xiong, Ying | |
dc.contributor.author | Watari, Hidemichi | |
dc.contributor.author | Konno, Yosuke | |
dc.contributor.author | Hanley, Sharon J. B. | |
dc.contributor.author | Noguchi, Masayuki | |
dc.contributor.author | Hirata, Noriyuki | |
dc.contributor.author | Suizu, Futoshi | |
dc.contributor.author | Yamada, Takahiro | |
dc.contributor.author | Kudo, Masataka | |
dc.contributor.author | Sakuragi, Noriaki | |
dc.date.accessioned | 2023-02-01T11:30:01Z | |
dc.date.available | 2023-02-01T11:30:01Z | |
dc.date.issued | 2017-01-10 | |
dc.identifier.citation | Ihira , K , Dong , P , Xiong , Y , Watari , H , Konno , Y , Hanley , S J B , Noguchi , M , Hirata , N , Suizu , F , Yamada , T , Kudo , M & Sakuragi , N 2017 , ' EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis. ' , Oncotarget , vol. 8 , no. 8 , pp. 13509-13520 . https://doi.org/10.18632/oncotarget.14586 | en |
dc.identifier.issn | 1949-2553 | |
dc.identifier.other | PURE: 226327004 | |
dc.identifier.other | PURE UUID: 7ea1e0cf-0e49-42db-9b53-8baceedada72 | |
dc.identifier.other | RIS: urn:E44689D24800DB1E42C1AAE13FF329BF | |
dc.identifier.other | ORCID: /0000-0002-7554-004X/work/127304245 | |
dc.identifier.other | Scopus: 85013453569 | |
dc.identifier.uri | https://hdl.handle.net/2164/19955 | |
dc.description | ACKNOWLEDGMENTS We thank Dr. Zhujie Xu for experimental assistance. GRANT SUPPORT This work was funded by a grant from the Department of Women’s Health Educational System, a Grant-in-Aid for Scientific Research (C) (15K10697 and 16K11123) and by the Science and Technology Planning Project of Guangdong Province, China (2013B021800155). | en |
dc.format.extent | 12 | |
dc.language.iso | eng | |
dc.relation.ispartof | Oncotarget | en |
dc.rights | All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License. https://creativecommons.org/licenses/by/3.0/ | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | 5-AZA-CdR | en |
dc.subject | endometrial cancer | en |
dc.subject | EZH2 | en |
dc.subject | GSK343 | en |
dc.subject | miR-361 | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis. | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.18632/oncotarget.14586 | |
dc.identifier.vol | 8 | en |
dc.identifier.iss | 8 | en |